Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sangamo Therapeutics Inc (NASDAQ:SGMO)

4.35
BATS BZX Real-Time Price
As of 11:18am ET
 +0.30 / +7.41%
Today’s Change
2.65
Today|||52-Week Range
7.60
+42.62%
Year-to-Date
Biotech Premarket Movers: Vertex, Sangamo, Depomed
9:37am / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close4.05
Today’s open4.35
Day’s range4.20 - 4.35
Volume20,436
Average volume (3 months)793,144
Market cap$287.0M
Dividend yield--
Data as of 11:18am ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)-75.86%
Earnings growth (this year)-21.24%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-50.96%
P/E ratioNM
Price/Sales11.10
Price/Book2.11

Competitors

 Today’s
change
Today’s
% change
NKNantKwest Inc+0.08+2.22%
VYGRVoyager Therapeutics...+0.46+3.93%
ONVOOrganovo Holdings In...+0.11+3.63%
SELBSelecta Biosciences ...-0.14-1.03%
Data as of 11:23am ET, 03/29/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$19.4M
Annual profit (last year)-$71.7M
Net profit margin-369.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts


Search for Jobs